US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist
  • 18.040
  • -0.140-0.77%
Close Oct 4 16:00 ET
  • 18.040
  • 0.0000.00%
Post 16:20 ET
1.38BMarket Cap-8089P/E (TTM)

Kura Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
41.00%56.4M
48.91%54.45M
18.55%165.8M
33.01%46.76M
16.07%42.47M
13.22%40M
11.54%36.57M
6.56%139.87M
6.41%35.16M
8.66%36.59M
Selling and administrative expenses
41.08%16.68M
59.87%18.18M
7.47%50.57M
13.94%14.23M
13.11%13.15M
6.74%11.82M
-4.17%11.37M
1.11%47.05M
3.36%12.49M
2.75%11.62M
-General and administrative expense
41.08%16.68M
59.87%18.18M
7.47%50.57M
13.94%14.23M
13.11%13.15M
6.74%11.82M
-4.17%11.37M
1.11%47.05M
3.36%12.49M
2.75%11.62M
Research and development costs
40.97%39.73M
43.97%36.27M
24.16%115.24M
43.52%32.53M
17.44%29.33M
16.18%28.18M
20.46%25.19M
9.55%92.81M
8.17%22.67M
11.65%24.97M
Operating profit
-41.00%-56.4M
-48.91%-54.45M
-18.55%-165.8M
-33.01%-46.76M
-16.07%-42.47M
-13.22%-40M
-11.54%-36.57M
-6.56%-139.87M
-6.41%-35.16M
-8.66%-36.59M
Net non-operating interest income expense
96.78%5.57M
97.32%4.93M
227.28%13.17M
94.71%3.98M
255.14%3.87M
401.60%2.83M
658.97%2.5M
408.21%4.03M
592.20%2.04M
250.48%1.09M
Non-operating interest income
85.73%5.97M
86.12%5.33M
246.07%14.72M
92.43%4.37M
292.20%4.28M
470.21%3.22M
769.60%2.86M
252.74%4.25M
669.83%2.27M
250.48%1.09M
Non-operating interest expense
4.91%406K
9.34%398K
576.42%1.55M
72.05%394K
--404K
--387K
--364K
-44.69%229K
--229K
--0
Other net income (expense)
Income before tax
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
-6.41%-35.5M
Income tax
Net income
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
-6.41%-35.5M
Net income continuous Operations
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
-6.41%-35.5M
Minority interest income
Net income attributable to the parent company
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
-6.41%-35.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
-6.41%-35.5M
Basic earnings per share
-11.32%-0.59
-18.00%-0.59
-2.46%-2.08
-12.24%-0.55
5.66%-0.5
-1.92%-0.53
-2.04%-0.5
-3.05%-2.03
0.00%-0.49
-6.00%-0.53
Diluted earnings per share
-11.32%-0.59
-18.00%-0.59
-2.46%-2.08
-12.24%-0.55
5.66%-0.5
-1.92%-0.53
-2.04%-0.5
-3.05%-2.03
0.00%-0.49
-6.00%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 41.00%56.4M48.91%54.45M18.55%165.8M33.01%46.76M16.07%42.47M13.22%40M11.54%36.57M6.56%139.87M6.41%35.16M8.66%36.59M
Selling and administrative expenses 41.08%16.68M59.87%18.18M7.47%50.57M13.94%14.23M13.11%13.15M6.74%11.82M-4.17%11.37M1.11%47.05M3.36%12.49M2.75%11.62M
-General and administrative expense 41.08%16.68M59.87%18.18M7.47%50.57M13.94%14.23M13.11%13.15M6.74%11.82M-4.17%11.37M1.11%47.05M3.36%12.49M2.75%11.62M
Research and development costs 40.97%39.73M43.97%36.27M24.16%115.24M43.52%32.53M17.44%29.33M16.18%28.18M20.46%25.19M9.55%92.81M8.17%22.67M11.65%24.97M
Operating profit -41.00%-56.4M-48.91%-54.45M-18.55%-165.8M-33.01%-46.76M-16.07%-42.47M-13.22%-40M-11.54%-36.57M-6.56%-139.87M-6.41%-35.16M-8.66%-36.59M
Net non-operating interest income expense 96.78%5.57M97.32%4.93M227.28%13.17M94.71%3.98M255.14%3.87M401.60%2.83M658.97%2.5M408.21%4.03M592.20%2.04M250.48%1.09M
Non-operating interest income 85.73%5.97M86.12%5.33M246.07%14.72M92.43%4.37M292.20%4.28M470.21%3.22M769.60%2.86M252.74%4.25M669.83%2.27M250.48%1.09M
Non-operating interest expense 4.91%406K9.34%398K576.42%1.55M72.05%394K--404K--387K--364K-44.69%229K--229K--0
Other net income (expense)
Income before tax -36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M-6.41%-35.5M
Income tax
Net income -36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M-6.41%-35.5M
Net income continuous Operations -36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M-6.41%-35.5M
Minority interest income
Net income attributable to the parent company -36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M-6.41%-35.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M-6.41%-35.5M
Basic earnings per share -11.32%-0.59-18.00%-0.59-2.46%-2.08-12.24%-0.555.66%-0.5-1.92%-0.53-2.04%-0.5-3.05%-2.030.00%-0.49-6.00%-0.53
Diluted earnings per share -11.32%-0.59-18.00%-0.59-2.46%-2.08-12.24%-0.555.66%-0.5-1.92%-0.53-2.04%-0.5-3.05%-2.030.00%-0.49-6.00%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data